Barr Pharmaceuticals, Inc. subsidiary, Barr Laboratories, Inc., wins favorable ruling in U.S. District Court for Delaware

New Blue Inspection provides API Audits and checks GMPs

Barr and Bayer Sign Agreements for Launch of Generic Yasmin(R) and Yaz(R) Oral Contraceptives

Kendle will be exhibiting and speaking at Drug Information Association (DIA) 44th Annual Meeting, June 22-26, 2008

The state-of-the-art facility began testing in May 2008

New Kansas Bioscience Authority (KBA) helps companies develop new treatments

BASF commits to voluntary compliance of current cGMPs for excipients

As the Japanese market opens up, businesses see more opportunity in the 2nd largest market

Company sells API business to 3i for $365 Million.

They are expected to be granted approval to market generic form of Diovan in 2012

AdreView, a a molecular imaging agent for the detection of neuroendocrine tumors is under priority review

This is Aurobindo's 70th approval from the FDA.

New catalyst technology delivers higher productivity, cost savings and reduced waste for pharmaceutical companies.

AGI Therapeutics presented key findings for Rezular(TM) at Digestive Disease Week in San Diego

Google Health now publicly available, but privacy issues are still a concern.